{"date":"2026-04-19","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6620-2026-04-19-1304-y7g6y7","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-04-19","time":"13:04:27","subject":"代子公司Handa Oncology, LLC公告505(b)(2)新藥HND-039美國FDA藥品審查訴願案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-04-19 13:04，「代子公司Handa Oncology, LLC公告505(b)(2)新藥HND-039美國FDA藥品審查訴願案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}